Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Henry Schein Inc(HSIC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HSIC
11/06/2026: HSIC (1-star) is currently NOT-A-BUY. Pass it for now.
Henry Schein Inc is a global distributor of healthcare products and technology solutions for dental, medical, and veterinary practices. The company has a leading position in the dental supply market and is known for its ability to integrate smaller distributors into its vast logistics network. Its primary growth opportunity lies in digitizing the dental clinic through practice management software and digital imaging workflows. However, the company faces risks from intensifying e-commerce competition and the consolidation of independent healthcare providers. It is generally suitable for value-oriented investors seeking a stable, long-term industry participant, though it lacks the dividend yield often favored by pure income investors.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers steady, predictable growth rather than high-octane expansion. |
| Momentum investor | Weak fit | The stock typically exhibits low beta and steady price action rather than rapid momentum breakouts. |
| Value investor | Strong fit | The company is often valued based on its defensive characteristics and reliable cash flow generation. |
| Dividend investor | Weak fit | The company historically prioritizes share buybacks and reinvestment over dividend payments. |
| Low-risk investor | Strong fit | Its role as an essential supplier to healthcare providers provides significant business durability. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Low | The stock is generally less volatile than high-growth tech or biotech peers. |
| Valuation risk | Medium | The stock is subject to market re-ratings based on interest rate environments and healthcare spending outlooks. |
| Competition risk (E-commerce expansion) | Medium / high | The entry of mass-market e-commerce players into medical distribution threatens traditional pricing models. |
| Business quality | Strong | The company has a long-standing history and a critical role in the healthcare supply chain. |
| Dividend income | Low / none | The company does not provide a reliable dividend stream for income-focused investors. |
| Execution risk | Medium | Successful growth relies on the consistent integration of numerous smaller acquisitions. |
Analysis of Past Performance
Type Stock | Historic Profit -17.12% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.43B USD | Price to earnings Ratio 23.37 | 1Y Target Price 96.93 |
Price to earnings Ratio 23.37 | 1Y Target Price 96.93 | ||
Volume (30-day avg) 1.5M shares | Beta 0.86 | 52 Weeks Range 68.70 - 92.18 | Updated Date 11/06/2026 |
52 Weeks Range 68.70 - 92.18 | Updated Date 11/06/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.65 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Dental | Dental consumables, equipment, and integrated digital dentistry software. | This is the core of the business, providing recurring revenue from essential supplies. |
| Medical | Clinical products, lab diagnostics, and vaccines for office-based practices. | Provides stable, volume-driven revenue from the broader healthcare provider market. |
| Geography (North America vs. International) | Sales across US/Canada and diverse international markets including Europe and Australia. | International exposure provides geographic diversification but introduces currency fluctuation risks. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When Before Market | Estimate 1.34 | Actual 1.56 |
Profitability
Profit Margin 3.07% | Operating Margin (TTM) 6.19% |
Management Effectiveness
Return on Assets (TTM) 4.31% | Return on Equity (TTM) 9.2% |
Valuation
Trailing PE 23.37 | Forward PE 14.95 | Enterprise Value 13.46B | Price to Sales(TTM) 0.69 |
Enterprise Value 13.46B | Price to Sales(TTM) 0.69 | ||
Enterprise Value to Revenue 0.98 | Enterprise Value to EBITDA 12.87 | Shares Outstanding 110.54M | Shares Floating 90.96M |
Shares Outstanding 110.54M | Shares Floating 90.96M | ||
Percent Insiders 0.84 | Percent Institutions 112.28 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.